Auditory Masking Effects on Speech Fluency in Aphasia and Apraxia of Speech

NCT ID: NCT02094014

Last Updated: 2016-05-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

46 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-03-31

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Impaired speech production is a major obstacle to full participation in life roles by stroke survivors with aphasia and apraxia of speech. The proposed study will demonstrate the short-term effects of auditory masking on speech disfluencies and identify individual factors that predict a positive response, enabling future work to develop auditory masking as a treatment adjuvant targeting long-term improvement in speech. Providing an additional treatment option for adults with aphasia and apraxia of speech will have the clear benefit of improving quality of life and allowing individuals to participate more actively in their health care decisions through improved communication.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objective of this research is to test the short-term effects of listening to noise (i.e. auditory feedback masking) on speech fluency in stroke survivors with aphasia and apraxia of speech. People with nonfluent types of aphasia frequently have apraxia of speech, which affects the motor programming of speech movements, causing distortions, slow rate, and speech disfluencies that impede the forward flow of communication. Speaking while listening to noise (e.g. auditory masking) is known to reduce disfluencies and increase speech rate in people who stutter. This method has been tested in people with aphasia, resulting in positive effects on speech production for a subset of those tested. The investigators contend that individuals who have apraxia of speech in addition to aphasia are most likely to benefit from auditory masking, but most previous studies did not test participants for apraxia of speech. In addition, though masking is most likely to affect speech disfluencies, previous studies did not measures disfluencies. The proposed work has two specific aims. Aim 1 will determine the short-term effect of auditory masking, provided on a single day, on speech fluency in stroke survivors with aphasia and apraxia of speech. Aim 2 will identify individual factors that predict a positive response, including presence of apraxia of speech, lesion characteristics, and type of aphasia (e.g. Broca's, Wernicke's). Voxel-based lesion analysis techniques will be used to determine sites of lesion associated with positive and negative response to auditory masking. Completion of this study will remove barriers to studying auditory masking as a technique for clinical intervention, but also as a research tool for behavioral neuroscientists probing the speech motor control system in speakers with aphasia and apraxia of speech.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Apraxia of Speech Aphasia Cerebrovascular Accident

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Aphasic/Apraxic Participants

The aphasic/apraxic participant group will include 30 adults who have had strokes affecting their ability to communicate verbally, broadly classified as aphasic and including individuals with and without apraxia of speech (AOS).

Participants will speak under Masked Auditory Feedback, Altered Auditory Feedback, and Normal Auditory Feedback.

Normal Auditory Feedback

Intervention Type BEHAVIORAL

Participants will produce sentences under normal speaking conditions, able to hear their own speech.

Masked Auditory Feedback

Intervention Type BEHAVIORAL

Participants will produce sentences while listening to speech-shaped noise at 85 decibels (sound pressure level) to mask ability to hear their own speech.

Altered Auditory Feedback

Intervention Type BEHAVIORAL

Participants will produce sentences while listening to their speech shifted up one octave and delayed.

Neurologically Healthy Participants

The neurologically healthy participant group will include 15 adults with no history of stroke or developmental speech or language disorder.

Participants will speak under Masked Auditory Feedback, Altered Auditory Feedback, and Normal Auditory Feedback.

Normal Auditory Feedback

Intervention Type BEHAVIORAL

Participants will produce sentences under normal speaking conditions, able to hear their own speech.

Masked Auditory Feedback

Intervention Type BEHAVIORAL

Participants will produce sentences while listening to speech-shaped noise at 85 decibels (sound pressure level) to mask ability to hear their own speech.

Altered Auditory Feedback

Intervention Type BEHAVIORAL

Participants will produce sentences while listening to their speech shifted up one octave and delayed.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Normal Auditory Feedback

Participants will produce sentences under normal speaking conditions, able to hear their own speech.

Intervention Type BEHAVIORAL

Masked Auditory Feedback

Participants will produce sentences while listening to speech-shaped noise at 85 decibels (sound pressure level) to mask ability to hear their own speech.

Intervention Type BEHAVIORAL

Altered Auditory Feedback

Participants will produce sentences while listening to their speech shifted up one octave and delayed.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Masking Noise Delayed and pitch-shifted feedback

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Single left-hemisphere cerebrovascular accident
* Speech errors are present, but participant is able to produce approximations of words or sentences by reading or repetition; \< 90% and \> 10% on Chapel Hill Multilingual Intelligibility Test (Haley, 2011)
* Right-handed prior to stroke by report
* Normal visual attention, acuity, and color vision
* Pure-tone threshold \<= 40 decibels in at least one ear


* Matched in age and sex to a participant with aphasia
* score of 90% or higher on the single-word intelligibility test
* Right-handed prior to stroke by report
* Normal visual attention, acuity, and color vision
* Pure-tone threshold \<= 40 decibels in at least one ear

Exclusion Criteria

* Predominating disorders of cognition or hearing (e.g. dementia, hearing impairment).
* Presence of degenerative neurological illness (e.g. Parkinson's disease, amyotrophic lateral sclerosis, primary progressive aphasia).


* History of stroke
* History of developmental speech or language disorder
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

Sponsor Role collaborator

University of North Carolina, Chapel Hill

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Adam Jacks, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

University of North Carolina, Chapel Hill

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of North Carolina School of Medicine

Chapel Hill, North Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R03DC011881

Identifier Type: NIH

Identifier Source: secondary_id

View Link

10-0503

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Neuroplasticity Biomarkers in Aphasia
NCT06471127 RECRUITING NA
MIT Intensive Treatment Study
NCT06213376 COMPLETED NA